Pediatrics & Neonatology
Volume 51, Issue 1 , Pages 14-18 , February 2010

Clinical Efficacy of House Dust Mite-specific Immunotherapy in Asthmatic Children

Received 3 March 2009 ,Revised 23 April 2009 ,Accepted 22 May 2009.

References 

  1. Noon L . Prophylactic inoculation against hay fever . Lancet . 1911;1:1572–1573
  2. Cooke RA . Hay fever and asthma: the uses and limitation of desensitization . N Y Med J . 1918;107:577–583
  3. Inal A , Altintas DU , Yilmaz M , Karakoc GB , Kendirli SG , Sertdemir Y . Prevention of new sensitizations by specific immunotherapy in children with rhinitis and/or asthma monosensitized to house dust mite . J Investig Allergol Clin Immunol . 2007;17:85–91
  4. Malling HJ , Weeke B . Position paper: immunotherapy . Allergy . 1993;48:S7–35
  5. Bousquet J , Michel FB . Specific immunotherapy in asthma: is it effective? . J Allergy Clin Immunol . 1994;94:1–11
  6. Abramson MJ , Puy RM , Weiner JM . Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials . Am J Respir Crit Care Med . 1995;151:969–974
  7. Adkinson NF , Eggleston PA , Eney D , et al.   A controlled trial of immunotherapy for asthma in allergic children . N Engl J Med . 1997;336:324–331
  8. Berg T , Nordvall L , Lanner A . Clinical studies of a purified timothy pollen extract. Desensitization therapy with a purified timothy pollen preparation compared to a crude timothy pollen extract. I. Results of tests in vivo . Int Arch Allergy Appl Immunol . 1980;63:266–274
  9. Bosquet J , Becker WM , Hejjaoni A , et al.   Differences in clinical and immunologic reactivities of patients allergic to grass pollen and multiple pollen species. II. Efficacy of a double-blind placebo controlled specific immunotherapy with standardized extracts . J Allergy Clin Immunol . 1991;88:43–53
  10. Negrini AC . Immunotherapy for respiratory allergic diseases: indications, efficacy and monitoring . Allergy Immunol . 1993;25:431–435
  11. Global Initiative for Asthma(GINA)  . GINA report, global strategy for asthma management and prevention . Bethesda, MD: National Institutes of Health; 2004; NIH publication 02–3659.
  12. Voorhost R , Spieksma-Boezeman MJE , Spieksma FTM . Is a mite (Dermatophagoides sp) the producer of the house dust allergen? . Allerg Asthma (Leipz) . 1964;6:329–334 [In German]
  13. Tang RB , Tsai LC , Hwang HM , et al.   The prevalence of allergic disease and IgE antibodies to house dust mite in school children in Taiwan . Clin Exp Allergy . 1990;20:33–38
  14. Tang RB , Wu KK . Total serum IgE, allergy skin testing, and the radioallergosorbent test for the diagnosis of allergy in asthmatic children . Ann Allergy . 1989;64:432–435
  15. Hejjaoui A , Dhivert H , Michel FB , Bousquet J . Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. IV. Systemic reactions according to the immunotherapy schedule . J Allergy Clin Immunol . 1990;85:473–479
  16. Alvarez-Cuesta E , Bousquet J , Canonica GW , Durham SR , Malling HJ , Valovirta E . Standards for practical allergen-specific immunotherapy . Allergy . 2006;61(Suppl 82):1–20
  17. Steen N , Hutchinson A , McColl E , et al.   Development of a symptom based outcome measure for asthma . BMJ . 1994;309:1065–1068
  18. Di Bernardino C , Di Bernardino F , Colombo R , Angrisano A . A case control study of Dermatophagoides immunotherapy in children below 5 years of age . Allerg Immunol (Paris) . 2002;34:56–59
  19. British Society for Allergy and Clinical Immunology (BSACI) Working Party  . Position paper on allergen immunotherapy. Report of a BSACI working party . Clin Exp Allergy . 1993;23(Suppl 3):1–44
  20. Bousquet J , Lockey R , Malling HJ . Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper . J Allergy Clin Immunol . 1998;102:558–562
  21. Tsai LC , Tang RB , Hung MW , Chen HM , Tsai SJ . Expression of serum IL-2, IL2R, and CD8 levels during hyposensitization in house-dust-sensitive asthmatics . J Asthma . 1990;27:307–314
  22. Tsai LC , Tang RB , Hung MW , Chang ZN . Changes in the levels of house dust mite specific IgG4 during immuno-therapy in asthmatic children . Clin Exp Allergy . 1991;21:367–372
  23. Tsai LC , Hung MW , Tang RB . Changes of serum-specific IgE antibody titer during hyposensitization in mite-sensitive asthmatic children . J Asthma . 1990;27:95–100
  24. Creticos PS . The consideration of immunotherapy in the treatment of allergic asthma . J Allergy Clin Immunol . 2000;105:S559–S574
  25. Peat JK , Woolcock AJ , Cullen K . Rate of decline of lung function in subjects with asthma . Eur J Respir Dis . 1987;70:171–179
  26. Ulrik CS , Backer V , Dirksen A . A 10-year follow-up of 180 adults with bronchial asthma: factors important for the decline in lung function . Thorax . 1992;47:14–18
  27. Pifferi M , Baldini G , Marrazzini G , et al.   Benefits of immunotherapy with a standardized Dermatophagoides pteronyssinus extract in asthmatic children: a three-year prospective study . Allergy . 2002;57:785–790
  28. Wahn U . Immunotherapy in children . Curr Opin Allergy Clin Immunol . 2002;2:557–560
  29. Nelson HS . Efficacy and safety of allergen immunotherapy in children . Ann Allergy Asthma Immunol . 2006;96:S2–S5
  30. Jacobsen L , Niggemann B , Dreborg S , et al.   (The PAT investigator group). Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study . Allergy . 2007;62:943–948
  31. Passalacqua G , Durham SR . Global Allergy and Asthma European Network. Allergic rhinitis and its impact on asthma update: allergen immunotherapy . J Allergy Clin Immunol . 2007;119:881–891
  32. Winther L , Malling HJ , Mosbech H . Allergen-specific immunotherapy in birch-and grass-pollen-allergic rhinitis. II. Side-effects . Allergy . 2000;55:827–835

PII: S1875-9572(10)60004-6

doi: 10.1016/S1875-9572(10)60004-6

Pediatrics & Neonatology
Volume 51, Issue 1 , Pages 14-18 , February 2010

Article Tools